Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

2.

Studies point to redlining as a 'perfect storm' for breast cancer

3.

Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients

4.

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

5.

A study has developed molecular markers that predict meningioma recurrence.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot